What is Elite Pharmaceuticals 3-Year Share Buyback Ratio?
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Elite Pharmaceuticals's current 3-Year Share Buyback Ratio was -1.80%.
The historical rank and industry rank for Elite Pharmaceuticals's 3-Year Share Buyback Ratio or its related term are showing as below:
ELTP'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -98.1 Med: -15.65 Max: 3.2
Current: -1.8
During the past 13 years, Elite Pharmaceuticals's highest 3-Year Share Buyback Ratio was 3.20%. The lowest was -98.10%. And the median was -15.65%.
ELTP's 3-Year Share Buyback Ratio is ranked better than 51.63% of 674
companies
in the Drug Manufacturers industry
Industry Median: -2.1
vs ELTP: -1.80
Competitive Comparison of Elite Pharmaceuticals's 3-Year Share Buyback Ratio
For the Drug Manufacturers - Specialty & Generic subindustry, Elite Pharmaceuticals's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elite Pharmaceuticals's 3-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Elite Pharmaceuticals's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Elite Pharmaceuticals's 3-Year Share Buyback Ratio falls into.
Elite Pharmaceuticals 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
Elite Pharmaceuticals (OTCPK:ELTP) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Elite Pharmaceuticals 3-Year Share Buyback Ratio Related Terms
Thank you for viewing the detailed overview of Elite Pharmaceuticals's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Elite Pharmaceuticals Inc is a pharmaceutical company. It is principally engaged in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology. The company's operating segment includes Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). It generates maximum revenue from the ANDA segment. The company focuses on developing pain management products; manufacturing a line of generic pharmaceutical products with approved Abbreviated New Drug Applications; developing additional generic pharmaceutical products; development of other products in its pipeline including the products with its partners; and commercialization of new products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ELTP has been successfully added to your